Copy
CANCER CLINICAL TRIALS NEWSLETTER

Radiation therapy plus chemotherapy is the standard treatment for inoperable non-small cell lung cancer (NSCLC). Conventional radiation therapy is called photon therapy and uses x-ray beams. In this study, researchers are comparing chemotherapy plus photon therapy with chemotherapy plus proton therapy in patients with stage II-IIIB inoperable NSCLC. Proton therapy differs from photon therapy because the proton particles can stop shortly after passing through a tumor, and may therefore cause less damage to nearby healthy tissues than photon radiation therapy. Proton therapy may therefore enable doctors to give higher doses of therapy to the tumor. This study compares intravenous chemotherapy paired with either photon therapy or proton therapy, to determine how proton therapy compares with photon therapy for inoperable NSCLC. (RTOG 1308, IRB 2019-0686)

Debiopharm 1347-201
2019-0353
A Phase II basket study of the oral selective pan-FGFR inhibitor Debio 1347 in subjects with solid tumors harboring a fusion of FGFR1, FGFR2 or FGFR3
EMD Serono MS100070_0176
2019-0430
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants from Multiple Avelumab (MSB0010718C) Clinical Studies
Click Here to Download All Cancer Trials Open to Accrual
Questions?  Please call us at 513-584-7698, or email us!
UC experts research going keto to fight cancer

Scientists are studying whether an Atkins-type ketogenic diet could help make treatments for glioblastoma more effective
Click Here to Visit the UC Newsroom
Lung Cancer: Revolutionary Progress
& Future Directions


Saturday, Oct. 12, 2019  | 7:30 a.m.–1:30 p.m.
Courtyard by Marriott Rookwood
3813 Edwards Road, Cincinnati, OH 45209

Keynote Speaker:
Patrick Forde, M.B.B.Ch
Assistant Professor of Oncology
Director, Thoracic Oncology Clinical Research Program
Johns Hopkins University


Register online at regonline.com/UC-lungcancer2019 For more information or questions, email kelly.hummel@uc.edu, or call 513-558-2030.

View Flyer as PDF
Division of Hematology Oncology Grand Rounds Schedule
Facebook
Twitter
UC Health Office of Clinical Research
Email Us
Check out our YouTube chanel!
Copyright © 2019, All rights reserved.

UC Cancer Institute Clinical Trials Office
200 Albert Sabin Way
Suite 4002A, ML 0502
Cincinnati, OH 45267-0502
513-584-7698    F 513-558-0071

Unsubscribe to this newsletter by emailing:
natalie.ciulla@uc.edu






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
UCCI Clinical Trials · 200 Albert Sabin Way Ste 4002A · Ml 0502 · Cincinnati, OH 45267-0502 · USA